Compare Deutsche Bank AG (DB) vs Medpace Holdings Inc (MEDP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Deutsche Bank AG vs Medpace Holdings Inc — how do they compare? Deutsche Bank AG trades at $38.4 (market cap $71.96B), while Medpace Holdings Inc trades at $607 (market cap $16.90B). The key difference: Deutsche Bank AG is far larger — about 4.3× Medpace Holdings Inc's market cap, and Deutsche Bank AG pays a 3.04% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| DB | MEDP | |
|---|---|---|
Market Cap | $71.96B | $16.90B |
Sector | Financials | Technology |
52-Week High | $40.33 | $620.59 |
52-Week Low | $28.37 | $393.42 |
Dividend Yield | 3.04% | — |
Enterprise Value | — | $16.52B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Deutsche Bank AG
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →
